TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SRZN

Surrozen Inc

Healthcare · Biotechnology

16.50$ -0.1% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Surrozen Inc (SRZN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 116 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SRZN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
54 46 37 45 48 48 115 103 94 99 121 116
48 41 32 42 45 39 106 94 86 92 114 109
34 36 27 38 31 35 102 90 81 89 107 102
43 27 38 31 35 102 90 81 89 107 102
2.0 2.2 2.1 2.1 12 2.5 2.6 2.6 2.6 0.2 5.0 5.0
0.0
8.4 8.1 6.6 39 42 70 109 56 118 286 399 334
6.7 7.1 6.2 6.0 6.1 7.3 11 5.7 6.5 9.9 9.6 9.0
2.4 2.6 2.2 1.5 1.8 1.2 1.2 1.2 1.3 1.9 2.0
0.3 0.5 0.1 0.2 0.3 0.3 0.3 0.4 0.5 0.7 0.9 1.1
46 38 30 6.1 5.7 -21 5.7 47 -24 -188 -278 -219
-213 -222 -231 -256 -257 -285 -312 -272 -344 -527 -655 -605
2.0 2.1 2.1 3.2 3.2 3.3 3.6 8.5 8.6 9.1 11 23

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?